Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats

Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure

(2009) S. J. Thandapilly et al.   AMERICAN JOURNAL OF HYPERTENSION

New pharmacologic therapies for acute heart failure

(2009) Miguel Tavares et al.   CRITICAL CARE MEDICINE

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

(2009) Elif Tatlidede et al.   FREE RADICAL RESEARCH

Nutritional and Anti-Inflammatory Interventions in Chronic Heart Failure

(2008) Kamyar Kalantar-Zadeh et al.   AMERICAN JOURNAL OF CARDIOLOGY

Knockout of β1- and β2-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis

(2008) H Kiriazis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Overview of emerging pharmacologic agents for acute heart failure syndromes

(2008) Leonardo De Luca et al.   EUROPEAN JOURNAL OF HEART FAILURE

Pregnancy Reverses Hypertensive Remodeling of Cerebral Arteries

(2008) Marilyn J. Cipolla et al.   HYPERTENSION

Heart failure: Targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment

(2008) Michael V.G. Latronico et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt

(2008) Anita Y. M. Chan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effects of β-Blocker on Left Ventricular Remodeling in Rats with Volume Overload Cardiac Failure

(2008) Masayuki KOBAYASHI et al.   JOURNAL OF VETERINARY MEDICAL SCIENCE

Tackling heart failure in the twenty-first century

(2008) James O. Mudd et al.   NATURE